Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Evaxion A/S - Sponsored ADR (EVAX : NSDQ)

• Company Description    Evaxion A/S is a clinical-stage TechBio company specializing in developing AI-Immunology(TM) powered vaccines. Evaxion A/S, formerly known as Evaxion Biotech A/S, is based in COPENHAGEN, Denmark. Number of Employees: 46

• Price / Volume Information    Yesterday's Closing Price: $6.38 Daily Weekly Monthly 20 Day Moving Average: 559,480 shares Shares Outstanding: 6.32 (millions) Market Capitalization: $40.30 (millions) Beta: 0.28 52 Week High: $13.15 52 Week Low: $1.20 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week 8.14% 5.30% 12 Week 121.53% 112.34% Year To Date 50.93% 31.93%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL Dr. Neergaards Vej 5F - Hoersholm,G7 2970 DNK ph: 45-3131-9753 fax: - investor@evaxion-biotech.com http://www.evaxion-biotech.com

• General Corporate Information    Officers Christian Kanstrup - Chief Executive Officer Marianne Sogaard - Chairman of the Board of Directors Jesper Nyegaard Nissen - Chief Operating and Financial Officer Roberto Prego - Director Niels Iversen Moller - Director Peer Information Evaxion A/S - Sponsored ADR (HLIS) Evaxion A/S - Sponsored ADR (AZTA) Evaxion A/S - Sponsored ADR (APYI) Evaxion A/S - Sponsored ADR (RNVA) Evaxion A/S - Sponsored ADR (HMSY) Evaxion A/S - Sponsored ADR (LRSI) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: MEDICAL INFO SYS Sector: Medical CUSIP: 29970R303 SIC: 2836 Fiscal Year Fiscal Year End: December Last Reported Quarter: 09/01/25 Next Expected EPS Date: 04/07/26 Share - Related Items Shares Outstanding: 6.32 Most Recent Split Date: 1.00 (0.20:1) Beta: 0.28 Market Capitalization: $40.30 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $ Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $-1.50 Payout Ratio: Number of Estimates in the Fiscal Year Consensus: 1.00 Change In Payout Ratio: Estmated Long-Term EPS Growth Rate: % Last Dividend Paid: NA - $0.00 Next EPS Report Date: 04/07/26

• Fundamental Ratios P/E Current FY Estimate: - Trailing 12 Months: - PEG Ratio: - Price Ratios Price/Book: 2.43 Price/Cash Flow: - Price / Sales: 12.05 EPS Growth vs. Year Ago Period: 465.00% vs. Previous Quarter: 196.05% Sales Growth vs. Year Ago Period: 148.33% vs. Previous Quarter: 20,148.65% ROE 09/30/25 - -68.82 06/30/25 - -321.11 03/31/25 - -536.68 ROA 09/30/25 - -24.12 06/30/25 - -79.60 03/31/25 - -100.78 Current Ratio 09/30/25 - - 06/30/25 - 3.42 03/31/25 - - Quick Ratio 09/30/25 - - 06/30/25 - 3.42 03/31/25 - - Operating Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Net Margin 09/30/25 - - 06/30/25 - - 03/31/25 - - Pre-Tax Margin 09/30/25 - -82.98 06/30/25 - -400.88 03/31/25 - -428.27 Book Value 09/30/25 - 2.63 06/30/25 - 0.99 03/31/25 - 1.64 Inventory Turnover 09/30/25 - - 06/30/25 - - 03/31/25 - - Debt-to-Equity 09/30/25 - 0.00 06/30/25 - 1.73 03/31/25 - - Debt-to-Capital 09/30/25 - 0.00 06/30/25 - 63.31 03/31/25 - -

Powered by Zacks Investment Research ©